Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Predictive Oncology Return on Tangible Equity 2010-2023 | POAI

Current and historical return on tangible equity values for Predictive Oncology (POAI) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
  
Predictive Oncology Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2023-12-31 $-0.01B $0.01B -101.96%
2023-09-30 $-0.02B $0.01B -110.77%
2023-06-30 $-0.02B $0.01B -95.00%
2023-03-31 $-0.03B $0.02B -104.17%
2022-12-31 $-0.03B $0.02B -96.15%
2022-09-30 $-0.03B $0.03B -90.09%
2022-06-30 $-0.03B $0.03B -80.00%
2022-03-31 $-0.02B $0.03B -51.70%
2021-12-31 $-0.02B $0.03B -53.33%
2021-09-30 $-0.02B $0.05B -78.63%
2021-06-30 $-0.03B $0.05B -147.06%
2021-03-31 $-0.03B $0.03B -800.00%
2020-12-31 $-0.03B $-0.00B 432.00%
2020-09-30 $-0.03B $-0.00B 413.79%
2020-06-30 $-0.03B $-0.01B 327.27%
2020-03-31 $-0.02B $-0.01B 283.87%
2019-12-31 $-0.02B $-0.01B 347.83%
2019-09-30 $-0.01B $-0.01B 225.00%
2019-06-30 $-0.01B $-0.01B 533.33%
2019-03-31 $-0.01B $-0.00B -1466.67%
2018-12-31 $-0.01B $-0.00B -444.44%
2018-09-30 $-0.01B $0.00B -246.15%
2018-06-30 $-0.01B $0.00B -184.62%
2018-03-31 $-0.01B $0.01B -215.38%
2017-12-31 $-0.01B $0.00B -200.00%
2017-09-30 $-0.01B $0.00B -240.00%
2017-06-30 $-0.01B $0.00B -300.00%
2017-03-31 $-0.01B $0.00B -400.00%
2016-12-31 $-0.01B $0.00B -700.00%
2016-09-30 $-0.01B $0.00B -457.14%
2016-06-30 $-0.01B $0.00B -246.15%
2016-03-31 $-0.01B $0.00B -400.00%
2015-12-31 $-0.00B $0.00B 800.00%
2015-09-30 $-0.00B $0.01B 133.33%
2015-06-30 $-0.00B $-0.01B 72.73%
2015-03-31 $-0.01B $-0.01B 105.26%
2014-12-31 $-0.01B $-0.01B 186.67%
2014-09-30 $-0.01B $-0.00B 233.33%
2014-06-30 $-0.01B $-0.00B 444.44%
2014-03-31 $-0.01B $-0.00B 360.00%
2013-12-31 $-0.01B $-0.00B 327.27%
2013-09-30 $-0.01B $-0.00B 327.27%
2013-06-30 $-0.01B $-0.00B 266.67%
2013-03-31 $-0.01B $-0.00B 360.00%
2012-12-31 $-0.01B $-0.00B 320.00%
2012-09-30 $-0.01B $-0.00B 360.00%
2012-06-30 $-0.01B $-0.00B 254.55%
2012-03-31 $-0.01B $-0.00B 166.67%
2011-12-31 $-0.00B $-0.00B 145.45%
2011-09-30 $-0.00B $-0.00B 40.00%
2011-06-30 $0.00B $-0.00B 0.00%
2011-03-31 $0.00B $-0.00B 0.00%
2010-12-31 $-0.00B $-0.00B 44.44%
2010-09-30 $-0.00B $-0.00B 44.44%
2010-06-30 $-0.00B $-0.00B 88.89%
2010-03-31 $-0.00B $-0.00B 171.43%
2009-12-31 $-0.00B $-0.00B 300.00%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.006B $0.002B
Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $39.354B 21.89
Inspire Medical Systems (INSP) United States $7.194B 0.00
IRhythm Technologies (IRTC) United States $3.483B 0.00
Axonics (AXNX) United States $3.401B 0.00
10x Genomics (TXG) United States $3.288B 0.00
Enovis (ENOV) United States $3.030B 23.02
Azenta (AZTA) United States $2.910B 237.18
Olink Holding AB (publ) (OLK) Sweden $2.840B 0.00
Hims & Hers Health (HIMS) United States $2.678B 0.00
Privia Health (PRVA) United States $2.167B 96.11
Schrodinger (SDGR) United States $1.733B 0.00
Omnicell (OMCL) United States $1.279B 31.30
Phreesia (PHR) United States $1.162B 0.00
Definitive Healthcare (DH) United States $0.823B 0.00
Standard BioTools (LAB) United States $0.708B 0.00
Fulgent Genetics (FLGT) United States $0.601B 0.00
Talkspace (TALK) United States $0.527B 0.00
Health Catalyst (HCAT) United States $0.353B 0.00
Clover Health Investments (CLOV) United States $0.337B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.328B 0.00
Pulmonx (LUNG) United States $0.281B 0.00
Butterfly Network (BFLY) United States $0.162B 0.00
American Well (AMWL) United States $0.153B 0.00
MSP Recovery (LIFW) United States $0.141B 0.00
P3 Health Partners (PIII) United States $0.141B 0.00
Augmedix (AUGX) United States $0.139B 0.00
Outset Medical (OM) United States $0.124B 0.00
TruBridge (TBRG) United States $0.118B 5.03
111 (YI) China $0.086B 0.00
SHL Telemedicine (SHLT) Israel $0.082B 0.00
Future Health ESG (FHLT) United States $0.073B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.048B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.035B 0.00
Movano (MOVE) United States $0.026B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Cue Health (HLTH) United States $0.022B 0.00
Akili (AKLI) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
Strata Skin Sciences (SSKN) United States $0.018B 0.00
CareCloud (CCLD) United States $0.017B 0.00
ETAO (ETAO) United States $0.015B 0.00
Biotricity (BTCY) United States $0.012B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00